Induction of CD28 on the new myeloma cell line MOLP-8 with t(11;14)(q13;q32) expressing δ/λ type immunoglobulin

Leukemia Research

Volumn 28, Issue 8, 2004, Pages 869-877

  Matsuo, Yoshinobu ^a   Drexler, Hans G ^b   Harashima, Akira ^a   Okochi, Ayumi ^a   Hasegawa, Atsuhiko ^c   Kojima, Kensuke ^c   Orita, Kunzo ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

CD28; Cell adhesion; Cell line; Multiple myeloma

Indexed keywords

ALPHA2 INTEGRIN; BENCE JONES PROTEIN; BETA1 INTEGRIN; CD28 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; CD56 ANTIGEN; CD71 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; DEXAMETHASONE; DOXORUBICIN; GROWTH FACTOR; HERMES ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN LAMBDA CHAIN; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; MELPHALAN; PREDNISONE; SYNDECAN 1; VINCRISTINE;

ADULT; ARTICLE; B LYMPHOCYTE; BONE MARROW; CASE REPORT; CELL ADHESION; CELL LINE; CYTOPLASM; HUMAN; HUMAN CELL; HYPERAMMONEMIA; MALE; MULTIPLE MYELOMA; MYELOMA CELL; PLASMA CELL; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD28; ANTIGENS, SURFACE; CELL ADHESION; CELL DIVISION; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 14; HUMANS; IMMUNOGLOBULIN DELTA-CHAINS; IMMUNOGLOBULIN LAMBDA-CHAINS; INTEGRINS; KARYOTYPING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PLASMA CELLS; STROMAL CELLS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 2942527432     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.12.008     Document Type: Article

References (37)

1. Hallek M., Bergsagel P.L., Anderson K.C. Multiple myeloma: increasing evidence for a multistep transformation process. Blood. 91:1998;3-21
2. Klein B., Zhang X.G., Lu Z.Y., Bataille R. Interleukin-6 in human multiple myeloma. Blood. 85:1995;863-872
3. Matsuoka Y., Moore G.E., Yagi Y., Pressman D. Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc. Soc. Exp. Biol. Med. 125:1967;1246-1250
4. Drexler H.G., Matsuo Y. Malignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia. Leuk. Res. 24:2000;681-703
5. Nilsson K. Human B-lymphoid cell lines. Hum. Cell. 5:1992;25-41
6. Zhang X.G., Gaillard J.P., Robillard N., Lu Z.Y., Gu Z.J., Jourdan M., et al. Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood. 83:1994;3654-3663
7. Robillard N., Jego G., Pellat-Deceunynck C., Pineau D., Puthier D., Mellerin M.P., et al. CD28, a marker associated with tumoral expansion in multiple myeloma. Clin. Cancer Res. 4:1998;1521-1526
8. Shapiro V.S., Mollenauer M.N., Weiss A. Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression. Blood. 98:2001;187-193
9. Matsuo Y., Drexler H.G., Nishizaki C., Harashima A., Fukuda S., Kozuka T., et al. Human bone marrow stroma-dependent myeloma cell line MOLP-5 derived from a patient in leukaemic phase of multiple myeloma. Br. J. Haematol. 109:2000;54-63
10. F Mitelman, editor. ISCN. An international system for human cytogenetic nomenclature. S Karger, Basel; 1995.
11. Hopert A., Uphoff C.C., Wirth M., Hauser H., Drexler H.G. Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines. J. Immunol. Methods. 164:1993;91-100
12. Ambinder R.F., Lambe B.C., Mann R.B., Hayward S.D., Zehnbauer B.A., Burns W.S., et al. Oligonucleotides for polymerase chain reaction amplification and hybridization detection of Epstein-Barr virus DNA in clinical specimens. Mol. Cell Probes. 4:1990;397-407
13. Matsuo Y., Nishizaki C., Drexler H.G. Efficient DNA fingerprinting method for the identification of cross-culture contamination of cell lines. Hum. Cell. 12:1999;149-154
14. Gould J., Alexanian R., Goodacre A., Pathak S., Hecht B., Barlogie B. Plasma cell karyotype in multiple myeloma. Blood. 71:1988;453-456
15. Ohtsuki T., Yawata Y., Wada H., Sugihara T., Mori M., Namba M. Two human myeloma cell lines, amylase-producing KMS-12-PE and amylase-non-producing KMS-12-B.M., were established from a patient, having the same chromosome marker, t(1114)(q13q32). Br. J. Haematol. 73:1989;199-204
16. Tsujimoto Y., Yunis J., Onorato-Showe L., Erikson J., Nowell P.C., Croce C.M. Molecular cloning of the chromosomal break point of B-cell lymphomas and leukemias with t(11; 14) chromosome translocation. Science. 224:1984;1403-1406
17. Withers D.A., Harvey R.C., Faust J.B., Melnyk O., Carey K., Meeker T.C. Characterization of a candidate bcl-1 gene. Mol. Cell Biol. 10:1991;4846-4853
18. Drexler H.G., MacLeod R.A. Malignant hematopoietic cell lines: in vitro models for the study of mantle cell lymphoma. Leuk. Res. 26:2002;781-787
19. Barlogie B., Epstein J., Selvanayagam P., Alexanian R. Plasma cell myeloma: new biological insights and advances in therapy. Blood. 73:1989;865-879
20. Shimizu S., Yoshioka R., Hirose Y., Sugai S., Tachibana J., Konda S. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines. J. Exp. Med. 169:1989;339-344
21. Kubonishi I., Seto M., Shimamura T., Enzan H., Miyoshi I. The establishment of an interleukin-6-dependent myeloma cell line (FLAM-76) carrying t(11; 14)(q13; q32) chromosome abnormality from an aggressive non-secretory plasma cell leukemia. Cancer. 70:1992;1528-1535
22. Goto H., Shimazaki C., Tatsumi T., Yamagata N., Fujita N., Tsuchiya M., et al. Establishment of a novel myeloma cell line KPMM2 carrying t(3; 14)(q21; q32), which proliferates specifically in response to interleukin-6 through an autocrine mechanism. Leukemia. 9:1995;711-718
23. Manabe A., Murti K.G., Coustan-Smith E., Kumagai M., Behm F.G., Raimondi S.C., et al. Adhesion-dependent survival of normal and leukemic human B lymphoblasts on bone marrow stromal cells. Blood. 83:1994;758-766
24. Merville P., Dechanet J., Desmouliere A., Durand I., De Bouteiller O., Garrone P., et al. Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 183:1996;227-236
25. Cook G., Dumber M., Franklin I.M. The role of adhesion molecules in multiple myeloma. Acta Haematol. 97:1997;81-89
26. Ridley R.C., Xiao H., Hata H., Woodliff J., Epstein J., Sanderson R.D. Expression of syndecan regulates human myeloma plasma cells adhesion to type I collagen. Blood. 81:1993;767-774
27. Harashima A., Matsuo Y., Nishizaki C., Kozuka T., Fukuda S., Sezaki T., et al. Human bone marrow stroma-dependent myeloma sister cell lines MOLP-6 and MOLP-7 derived from a patient with multiple myeloma. Hum. Cell. 13:2000;43-54
28. Kozbor D., Moretta A., Messner H.A., Moretta L., Croce C.M. Tp44 molecules involved in antigen-independent T-cell activation are expressed on human plasma cells. J. Immunol. 138:1987;4128-4132
29. Pellat-Deceunynck C., Bataille R., Robillard N., Harousseau J.-L., Rapp M.-J., Juge-Morineau N., et al. Expression of CD28 and CD40 in human myeloma cells: a comparative study with normal plasma cells. Blood. 84:1994;2597-2603
30. Zhang X.G., Olive D., Devos J., Rebouissou C., Ghitto-Ragueneau M., Ferlin M., et al. Malignant plasma cell lines express a functional CD28 molecule. Leukemia. 12:1998;610-618
31. Matsuzaki H., Hata H., Takeya M., Takatsuki K. Establishment and characterization of an amylase-producing human myeloma cell line. Blood. 72:1988;978-982
32. Taylor J.J. Hypercalcaemia in "non-secretory" myeloma. Haematologia. 19:1986;269-273
33. Fine P., Adler K., Gerstenfeld D. Idiopathic hyperammonemia after high-dose chemotherapy. Am. J. Med. 86:1989;629
34. Matsuzaki H., Hata H., Sonoki T., Matsuno F., Kuribayashi N., Yoshida M., et al. Serum amino acid disturbance in multiple myeloma with hyperammonemia. Int. J. Hematol. 61:1995;131-137
35. Otsuki T., Yamada O., Sakaguchi H., Ichiki T., Kouguchi K., Wada H., et al. In vitro excess ammonia production in human myeloma cell lines. Leukemia. 12:1998;1149-1158
36. Otsuki T., Nakazawa N., Taniwaki M., Yamada O., Sakaguchi H., Wada H., et al. Establishment of a new human myeloma cell line, KMS-18, having t(4; 14)(p16.3; q32.3) derived from a case phenotypically transformed from Ig A-lambda to BJP-lambda, and associated with hyperammonemia. Int. J. Oncol. 12:1998;545-552
37. Matsuzaki H., Matsuno F., Yoshida M., Hata H., Okazaki K., Takatsuki K. Human myeloma cell line (KHM-4) established from a patient with multiple myeloma associated with hyperammonemia. Intern. Med. 31:1992;339-343